These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37425702)

  • 21. Fluoroquinolone resistance mechanisms in an Escherichia coli isolate, HUE1, without quinolone resistance-determining region mutations.
    Sato T; Yokota S; Uchida I; Okubo T; Usui M; Kusumoto M; Akiba M; Fujii N; Tamura Y
    Front Microbiol; 2013; 4():125. PubMed ID: 23745120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of fluoroquinolone resistance in Escherichia coli isolates from food-producing animals.
    Karczmarczyk M; Martins M; Quinn T; Leonard N; Fanning S
    Appl Environ Microbiol; 2011 Oct; 77(20):7113-20. PubMed ID: 21856834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
    Warner WA; Kuang SN; Hernandez R; Chong MC; Ewing PJ; Fleischer J; Meng J; Chu S; Terashita D; English L; Chen W; Xu HH
    BMC Infect Dis; 2016 May; 16():194. PubMed ID: 27146090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Biofilm Inhibitor Carolacton Enters Gram-Negative Cells: Studies Using a TolC-Deficient Strain of
    Donner J; Reck M; Bunk B; Jarek M; App CB; Meier-Kolthoff JP; Overmann J; Müller R; Kirschning A; Wagner-Döbler I
    mSphere; 2017; 2(5):. PubMed ID: 28959742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli.
    Opperman TJ; Kwasny SM; Kim HS; Nguyen ST; Houseweart C; D'Souza S; Walker GC; Peet NP; Nikaido H; Bowlin TL
    Antimicrob Agents Chemother; 2014; 58(2):722-33. PubMed ID: 24247144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TCA and SSRI Antidepressants Exert Selection Pressure for Efflux-Dependent Antibiotic Resistance Mechanisms in Escherichia coli.
    Ou J; Elizalde P; Guo HB; Qin H; Tobe BTD; Choy JS
    mBio; 2022 Dec; 13(6):e0219122. PubMed ID: 36374097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance.
    Gross CH; Parsons JD; Grossman TH; Charifson PS; Bellon S; Jernee J; Dwyer M; Chambers SP; Markland W; Botfield M; Raybuck SA
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1037-46. PubMed ID: 12604539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of highly ciprofloxacin resistance acinetobacter baumannii isolated from patients with burn wound infections in presence and absence of efflux pump inhibitor.
    Maleki MH; Jalilian FA; Khayat H; Mohammadi M; Pourahmad F; Asadollahi K; Pakzad I; Sadeghifard N; Soroush S; Emaneini M; Taherikalani M
    Maedica (Bucur); 2014 Jun; 9(2):162-7. PubMed ID: 25705272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of marbofloxacin administration on the emergence of marbofloxacin-resistant E. coli in faecal flora of goats and elucidation of molecular basis of resistance.
    Bhardwaj P; Kaur G; Rampal S
    J Glob Antimicrob Resist; 2020 Jun; 21():116-123. PubMed ID: 32302733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of mutational patterns in quinolone resistance-determining regions of GyrA and ParC of clinical isolates.
    Ostrer L; Khodursky RF; Johnson JR; Hiasa H; Khodursky A
    Int J Antimicrob Agents; 2019 Mar; 53(3):318-324. PubMed ID: 30582984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump.
    Grimsey EM; Fais C; Marshall RL; Ricci V; Ciusa ML; Stone JW; Ivens A; Malloci G; Ruggerone P; Vargiu AV; Piddock LJV
    mBio; 2020 Jun; 11(3):. PubMed ID: 32487753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and mechanisms of ciprofloxacin resistance in Escherichia coli isolated from hospitalized patients, healthy carriers, and wastewaters in Iran.
    Neyestani Z; Khademi F; Teimourpour R; Amani M; Arzanlou M
    BMC Microbiol; 2023 Jul; 23(1):191. PubMed ID: 37460988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of fluoroquinolone resistance: an update 1994-1998.
    Piddock LJ
    Drugs; 1999; 58 Suppl 2():11-8. PubMed ID: 10553699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark.
    Cavaco LM; Frimodt-Møller N; Hasman H; Guardabassi L; Nielsen L; Aarestrup FM
    Microb Drug Resist; 2008 Jun; 14(2):163-9. PubMed ID: 18500921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding site feature description of 2-substituted benzothiazoles as potential AcrAB-TolC efflux pump inhibitors in E. coli.
    Yilmaz S; Altinkanat-Gelmez G; Bolelli K; Guneser-Merdan D; Ufuk Over-Hasdemir M; Aki-Yalcin E; Yalcin I
    SAR QSAR Environ Res; 2015; 26(10):853-71. PubMed ID: 26559566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New dual ATP-competitive inhibitors of bacterial DNA gyrase and topoisomerase IV active against ESKAPE pathogens.
    Durcik M; Nyerges Á; Skok Ž; Skledar DG; Trontelj J; Zidar N; Ilaš J; Zega A; Cruz CD; Tammela P; Welin M; Kimbung YR; Focht D; Benek O; Révész T; Draskovits G; Szili PÉ; Daruka L; Pál C; Kikelj D; Mašič LP; Tomašič T
    Eur J Med Chem; 2021 Mar; 213():113200. PubMed ID: 33524686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanisms of antimicrobial resistance in fecal Escherichia coli of healthy dogs after enrofloxacin or amoxicillin administration.
    Aly SA; Debavalya N; Suh SJ; Oryazabal OA; Boothe DM
    Can J Microbiol; 2012 Nov; 58(11):1288-94. PubMed ID: 23145826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RND Pump-Mediated Efflux of Amotosalen, a Compound Used in Pathogen Inactivation Technology to Enhance Safety of Blood Transfusion Products, May Compromise Its Gram-Negative Anti-Bacterial Activity.
    Green AB; Chiaraviglio L; Truelson KA; Zulauf KE; Cui M; Zhang Z; Ware MP; Flegel WA; Haspel RL; Yu EW; Kirby JE
    mSphere; 2023 Apr; 8(2):e0067322. PubMed ID: 36853056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of different mechanisms to the resistance to fluoroquinolones in clinical isolates of Salmonella enterica.
    Rushdy AA; Mabrouk MI; Abu-Sef FA; Kheiralla ZH; Mohamed Abdel-All S; Saleh NM
    Braz J Infect Dis; 2013; 17(4):431-7. PubMed ID: 23742803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.